<?xml version="1.0" encoding="UTF-8"?>
<ref id="B24-viruses-12-00838">
 <label>24.</label>
 <element-citation publication-type="journal">
  <person-group person-group-type="author">
   <name>
    <surname>Oliveira</surname>
    <given-names>M.</given-names>
   </name>
   <name>
    <surname>Ibanescu</surname>
    <given-names>R.-I.</given-names>
   </name>
   <name>
    <surname>Anstett</surname>
    <given-names>K.</given-names>
   </name>
   <name>
    <surname>Mésplède</surname>
    <given-names>T.</given-names>
   </name>
   <name>
    <surname>Routy</surname>
    <given-names>J.-P.</given-names>
   </name>
   <name>
    <surname>Robbins</surname>
    <given-names>M.</given-names>
   </name>
   <name>
    <surname>Brenner</surname>
    <given-names>B.G.</given-names>
   </name>
  </person-group>
  <article-title>Selective resistance profiles emerging in patient-derived clinical isolates with cabotegravir, bictegravir, dolutegravir, and elvitegravir</article-title>
  <source>Retrovirology</source>
  <year>2018</year>
  <volume>15</volume>
  <fpage>56</fpage>
  <pub-id pub-id-type="doi">10.1186/s12977-018-0440-3</pub-id>
  <pub-id pub-id-type="pmid">30119633</pub-id>
 </element-citation>
</ref>
